Changes in SciBase’s financial calendar for 2021April 20, 2021
SciBase Holding AB (”SciBase” or the “Company”) has updated the Company’s financial calendar for 2021.
NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN SCIBASE HOLDING AB (PUBL)April 15, 2021
The shareholders in SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby given notice to attend the annual general meeting at 2:00 p.m. on Tuesday 18 May 2021. The meeting will be held through postal voting only (see below).
Nature article presents impact and importance of epithelial barrier damage on a range of common diseases.
STOCKHOLM, SWEDEN, - April 15, 2021 - SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today the publication of a groundbreaking article presenting the "epithelial barrier hypothesis" in Nature Reviews Immunology. The article was written by Professor Cezmi Akdis at the Swiss institute of Allergy and Asthma Research (SIAF). Prof. Akdis is the key research collaborator in SciBase's product development for skin barrier assessment. The article presents the background for the steep increase in allergic diseases over the last decades, and how this increase is connected to industrialization and modern lifestyle.
- Load more news...